These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23896345)

  • 1. The evolution of juvenile animal testing for small and large molecules.
    Baldrick P
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):125-35. PubMed ID: 23896345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile animal toxicity study designs to support pediatric drug development.
    Cappon GD; Bailey GP; Buschmann J; Feuston MH; Fisher JE; Hew KW; Hoberman AM; Ooshima Y; Stump DG; Hurtt ME
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):463-9. PubMed ID: 20025047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile animal testing in drug development--is it useful?
    Baldrick P
    Regul Toxicol Pharmacol; 2010; 57(2-3):291-9. PubMed ID: 20350578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile animal studies and pediatric drug development: a European regulatory perspective.
    Carleer J; Karres J
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):254-60. PubMed ID: 21638754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of juvenile animal studies "What have we learned from preclinical juvenile toxicity studies? II".
    Bailey GP; Mariën D
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):273-91. PubMed ID: 22623019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real life juvenile toxicity case studies: the good, the bad and the ugly.
    De Schaepdrijver L; Rouan MC; Raoof A; Bailey GP; De Zwart L; Monbaliu J; Coogan TP; Lammens L; Coussement W
    Reprod Toxicol; 2008 Sep; 26(1):54-5. PubMed ID: 18514481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile animal studies and pediatric drug development retrospective review: use in regulatory decisions and labeling.
    Tassinari MS; Benson K; Elayan I; Espandiari P; Davis-Bruno K
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):261-5. PubMed ID: 21594977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile Nonclinical Safety Studies in Support of Pediatric Drug Development.
    Barrow PC; Schmitt G
    Methods Mol Biol; 2017; 1641():25-67. PubMed ID: 28748457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile Animal Testing: Assessing Need and Use in the Drug Product Label.
    Baldrick P
    Ther Innov Regul Sci; 2018 Sep; 52(5):641-648. PubMed ID: 29714556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of juvenile animal studies.
    Leconte I; Bailey G; Davis-Bruno K; Hew KW; Kim J; Silva Lima B; Liminga U; Moffit J; De Schaepdrijver L; Schmitt G; Tassinari M; Thompson K; Hurtt M
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):292-303. PubMed ID: 22623020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing drugs for pediatric use: a role for juvenile animal studies?
    Baldrick P
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):381-9. PubMed ID: 15135215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of juvenile toxicity.
    Barrow PC; Barbellion S; Stadler J
    Methods Mol Biol; 2011; 691():17-35. PubMed ID: 20972745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile toxicity: are we asking the right questions?
    Downes N
    Toxicol Pathol; 2012 Jul; 40(5):830-7. PubMed ID: 22407308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What have we learned from pre-clinical juvenile toxicity studies?
    Bailey GP; Mariën D
    Reprod Toxicol; 2009 Sep; 28(2):226-9. PubMed ID: 19446432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-clinical safety assessment and toxicokinetics of voriconazole and anidulafungin in the juvenile rat: a combination study design in support of a Paediatric Investigation Plan.
    Cross DM; Chmielewski G; Lewis EM; Liu L; Modesitt MS; Ripp SL; Sawaryn CM; Bowman CJ
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):29-39. PubMed ID: 22343256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of juvenile animal studies: a pediatric clinical perspective.
    Rose K
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):252-3. PubMed ID: 21594978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical testing for teratogenicity and developmental toxicity: methods and limitations.
    Barrow PC
    Therapie; 2002; 57(2):109-14. PubMed ID: 12185956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The developmental toxicity testing of biologics.
    Hazelden KP
    Methods Mol Biol; 2013; 947():31-6. PubMed ID: 23138893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.